Filing Flows › Acadia Pharmaceuticals (ACAD) › Operating margin
Acadia Pharmaceuticals (ACAD) operating margin by quarter
Acadia Pharmaceuticals' operating margin was 21.0% in Q3 2026 (third quarter 2026), +8.7 pts from Q2 2026. Over the last 6 quarters it ranged from 6.1% (Q4 2025) to 21.0% (Q3 2026).
| Quarter | Operating margin | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | 21.0% | +8.7 pts | +8.1 pts |
| Q2 2026 | 12.3% | +6.2 pts | +0.0 pts |
| Q4 2025 | 6.1% | -6.7 pts | — |
| Q3 2025 | 12.8% | +0.6 pts | — |
| Q2 2025 | 12.2% | +4.3 pts | — |
| Q1 2025 | 7.9% | — | — |
Q3 2026 at a glance
Acadia Pharmaceuticals, Q3 2026: revenue $342M (+23% year over year), operating margin 21.0%, net earnings $53.5M, operating cash flow $11.5M. The chart follows the revenue to costs, profit and cash.
Questions
What is Acadia Pharmaceuticals' operating margin?
Acadia Pharmaceuticals' operating margin was 21.0% in Q3 2026 (third quarter 2026), +8.7 pts from Q2 2026.
How has Acadia Pharmaceuticals' operating margin changed?
Over the last 6 quarters it ranged from 6.1% (Q4 2025) to 21.0% (Q3 2026).
Q3 2026 results → · How Acadia Pharmaceuticals makes money →